Live Quote · NASDAQFRESHealthcare· Biotechnology

Fresh2 Group Limited

$0.85 23.42%($-0.26)
TickerSpark Score
44/100
Weak
60
Valuation
40
Profitability
55
Growth
36
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a FRES research report →

52-Week Range1% of range
Low
$0.73
Current
$0.85
High
$9.00
Company Overviewfresh2.co

About the company

Fresh2 Group Limited, a biotechnology company established in New York, New York, in 2010, officially adopted its current name in April 2023, having previously been known as AnPac Bio-Medical Science Co. , Ltd. The company is primarily engaged in the research, development, promotion, and sale of advanced multi-cancer screening and detection tests within the People's Republic of China, leveraging its proprietary cancer differentiation analysis (CDA) technology and associated devices for corporate and life insurance clients.

CEO
Haohan Xu
IPO
2020
Employees
75
HQ
New York City, NY, US

Price Chart

-78.75% · this period
$8.46$4.66$0.85Jan 19Jul 22Jan 21

Get TickerSpark's AI analysis on FRES

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in